Shang Wang

1.2k citations
69 papers · 798 indexed · h-index 18
Topics
Acute Ischemic Stroke Management (18 papers)Pulmonary Hypertension Research and Treatments (12 papers)Cerebrovascular and Carotid Artery Diseases (9 papers)

In The Last Decade

Shang Wang

66 papers receiving 784 citations

Peers

Shang Wang
Comparison fields: 5 of 102
  • Molecular Biology 181
  • Pulmonary and Respiratory Medicine 180
  • Cardiology and Cardiovascular Medicine 154
  • Epidemiology 150
  • Immunology 145
Replace Lili Xu with:
Lili Xu China
Radosław Kaźmierski Poland
Elena Masselli Italy
Maximilian Mauler Germany
Francesco Monaco Italy
Vittoriano Della Corte Italy
Akiko Sekiguchi Japan
Adrian Doroszko Poland
Jianyan Wen China
Yuechun Li China
Shang Wang relative to Lili Xu China Lili Xu's profile →
Citations per field
00.5×1.5×2.3×
Lili Xu · 1×
Citations per year

Countries citing papers authored by Shang Wang

Since Specialization
Citations

This map shows the geographic impact of Shang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shang Wang more than expected).

Fields of papers citing papers by Shang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shang Wang. The network helps show where Shang Wang may publish in the future.

Co-authorship network of co-authors of Shang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shang Wang. A scholar is included among the top collaborators of Shang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shang Wang. Shang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 11
3 1
4 0
5 1
6 20
7 26
8 2
9 3
10 1
11 0
12 7
13 7
14 56
15 2
16 4
17 35
18 17
19 9
20 11

About Shang Wang

Shang Wang is a scholar working on Internal Medicine, Issues, ethics and legal aspects and Rehabilitation, having authored 69 papers that have together received 798 indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (18 papers), Pulmonary Hypertension Research and Treatments (12 papers) and Cerebrovascular and Carotid Artery Diseases (9 papers). The work is most often cited by research in Internal Medicine (36 citations), Immunology (145 citations) and Cardiology and Cardiovascular Medicine (154 citations). Shang Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yunyun Xiong, Xiao‐Ping Zhong, Jinwook Shin, Biao Xu, Lian Wang, Jimin Gao, Cheuk‐Man Yu, Qing Shang, Jinhong Wu and Wenhai Deng. Their work appears in journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026